Hess Corporation (HES) has been the subject of significant interest with both purchases and sales taking place among diverse investors. Brevan Howard Capital Management LP has lowered its position while others such as CoreCommodity Management LLC and BNP Paribas Financial Markets have respectively sold and acquired considerable shares. Analysts present a mixed outlook on the company's health, with StockNews.com holding a neutral stance.
Company-issued reports indicate that Hess's revenue for 2025 Q1 fell short of expectations. Other proposed highlights include its presence in Guyana through a significant healthcare initiative, a proposed Chevron merger, and a regular quarterly dividend.β¨Q1 2025 results also show adjusted EPS of $1.81, beating estimates.
Notably, Chevron continues to express confidence in ongoing merger negotiations, having purchased approximately 5% of Hess stock recently. Despite revenue misses and sliding earnings, Hess shares continue to perform resiliently, earning a strength rating upgrade, and hitting key benchmarks.
Hess Corporation HES News Analytics from Fri, 02 Aug 2024 07:00:00 GMT to Sat, 10 May 2025 20:23:16 GMT - Rating 3 - Innovation -2 - Information 5 - Rumor 4
